Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.8
4.5
Journals
Cancers
Special Issues
Recent Advances in Colorectal Cancer Screening
cancers-logo
Submit to Cancers Review for Cancers Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Recent Advances in Colorectal Cancer Screening

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".

Deadline for manuscript submissions: closed (1 December 2024) | Viewed by 4647

Special Issue Editors

Dr. Andrea Burón

E-Mail Website
Guest Editor
1. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
2. RICAPPS (Research Network on Chronicity, Primary Care and Health Promotion), Madrid, Spain
Interests: epidemiology; colorectal cancer; screening and prevention; screening personalization; barriers and facilitators to screening; ethics in public health
Dr. Gemma Binefa

E-Mail Website
Guest Editor
1. Early Detection of Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
2. Ciber Salud Pública (CIBERESP), Instituto Salud Carlos III, Madrid, Spain
Interests: colorectal cancer; screening; quality indicators; adverse effects; barriers and facilitators to adherence

Special Issue Information

Dear Colleagues,

Colorectal cancer screening is nowadays widely carried out as an opportunistic intervention or as a population-based program. Although its efficacy is well documented, there are still many unanswered questions and challenges ahead. Coverage and uptake rates are below acceptable standards in many regions, with significant inequities being described. Personalized screening has gathered much attention in the last few years; however, despite substantial evidence that it may greatly benefit patients and reduce the disease burden, which strategy or combination of strategies is the most effective is still unknown. The fecal immunochemical test (FIT), sigmoidoscopy and colonoscopy are the most widely used screening and diagnostic tests, but more advanced and newer technologies are being proposed either as complementary or alternative tests in some settings. Biomarkers are one of these promising new technologies, although evidence of their effectiveness in real settings is still lacking.

This Special Issue aims to further advance the field of colorectal cancer screening via 1) increasing uptake and coverage rates; 2) reducing inequalities; 3) describing and tackling communication issues, enhancing informed participation; 4) proposing personalized screening strategies; 5) highlighting new screening and diagnostic tools. This Special Issue welcomes both original research articles and reviews.

Dr. Andrea Burón
Dr. Gemma Binefa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • colorectal cancer
  • screening
  • fecal immunochemical test
  • colonoscopy
  • personalization strategies
  • cancer inequalities
  • quality indicators
  • decision aids

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 258 KiB  
Article
Analysing Inequalities in Colorectal Cancer Screening Using an Individual Socioeconomic Status Index
by Paula Romeo-Cervera, Javier Martín-Pozuelo, Mercedes Vanaclocha-Espí, Marina Pinto-Carbó, Susana Castán-Cameo, Dolores Salas and Ana Molina-Barceló
Cancers 2024, 16(23), 3940; https://doi.org/10.3390/cancers16233940 - 25 Nov 2024
Viewed by 883
Abstract
Background/Objectives: An individual socioeconomic status index (ISESI) was used to analyse inequalities in participation and colonoscopy acceptance in the Valencia Region Colorectal Cancer Screening Programme (VR-CRCSP). Methods: This is a cross-sectional study of men and women aged 50–69 who had been invited to [...] Read more.
Background/Objectives: An individual socioeconomic status index (ISESI) was used to analyse inequalities in participation and colonoscopy acceptance in the Valencia Region Colorectal Cancer Screening Programme (VR-CRCSP). Methods: This is a cross-sectional study of men and women aged 50–69 who had been invited to participate in the VR-CRCSP as of February 2020 (N = 1,066,763). The variables included in the ISESI were nationality, employment status, disability, healthcare coverage, risk of vulnerability, and family size. The ISESI was categorised into quartiles (Qs), with Q4 corresponding to the lowest socioeconomic status (SES). Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using mixed logistic regression models. Results: The results showed that Q2 (OR = 1.30, CI = 1.28–1.33) and Q3 (OR = 1.07, CI = 1.05–1.09) are more likely to participate in the CRCSP than Q1 (the highest SES), and that Q4 (OR = 0.77, CI = 0.76–0.78) is less likely to participate than Q1. In addition, Q2 (OR = 2.03, CI = 1.78–2.32), Q3 (OR = 1.90, CI = 1.67–2.16), and Q4 (OR = 1.55, CI = 1.36–1.76) are more likely to accept a colonoscopy than Q1. The following socioeconomic characteristics were related to both non-participation and colonoscopy refusal: not Spanish, disabled, no family unit, at risk of social vulnerability, and private mutual health insurance. Conclusions: Inequalities were observed in VR-CRCSP participation and colonoscopy acceptance. Full article
(This article belongs to the Special Issue Recent Advances in Colorectal Cancer Screening)
10 pages, 1366 KiB  
Article
Interval Cancer in Population-Based Colorectal Screening Programmes: Incidence and Characteristics of Tumours
by Mercedes Vanaclocha-Espí, Marina Pinto-Carbó, Josefa Ibáñez, María José Valverde-Roig, Isabel Portillo, Francisco Pérez-Riquelme, Mariola de la Vega, Susana Castán-Cameo, Dolores Salas and Ana Molina-Barceló
Cancers 2024, 16(4), 769; https://doi.org/10.3390/cancers16040769 - 13 Feb 2024
Viewed by 1365
Abstract
The objective of this study is to evaluate interval cancer (IC) in colorectal cancer (CRC) screening, which is CRC diagnosed in an individual after having received a negative faecal occult blood test and before the next invitation to participate in screening. A follow-up [...] Read more.
The objective of this study is to evaluate interval cancer (IC) in colorectal cancer (CRC) screening, which is CRC diagnosed in an individual after having received a negative faecal occult blood test and before the next invitation to participate in screening. A follow-up study was conducted on a cohort of participants in the first three screening rounds of four colorectal cancer screening programmes in Spain, n = 664,993. A total of 321 ICs and 2120 screen-detected cancers (SCs) were found. The IC and SC rates were calculated for each guaiac (gFOBT) or immunochemical (FIT) test. A Cox regression model was used to estimate the hazard ratios (HR) of IC risk factors. A nested case–control study was carried out to compare IC and SC tumour characteristics. The IC rate was 1.16‰ with the gFOBT and 0.35‰ with the FIT. Men and people aged 60–69 showed an increased probability of IC (HR = 1.81 and HR = 1.95, respectively). There was a decreased probability of IC in individuals who regularly participated in screening, HR = 0.62 (0.47–0.82). IC risk gradually rose as the amount of Hb detected in the FIT increased. IC tumours were in more advanced stages and of a larger size than SC tumours, and they were mostly located in the cecum. These results may play a key role in future strategies for screening programmes, reducing IC incidence. Full article
(This article belongs to the Special Issue Recent Advances in Colorectal Cancer Screening)
►▼ Show Figures

Figure 1

Review

Jump to: Research

27 pages, 449 KiB  
Review
Current Progress in Clinical Research in Secondary Prevention and Early Detection of Colorectal Cancer
by Olga Partyka, Monika Pajewska, Aleksandra Czerw, Andrzej Deptała, Dominika Mękal, Katarzyna Sygit, Dariusz Kowalczyk, Elżbieta Cipora, Mateusz Kaczmarski, Lucyna Gazdowicz, Grażyna Dykowska, Zofia Sienkiewicz, Tomasz Banaś, Krzysztof Małecki, Elżbieta Grochans, Szymon Grochans, Anna Maria Cybulska, Daria Schneider-Matyka, Ewa Bandurska, Tomasz Bandurski, Jarosław Drobnik, Piotr Pobrotyn, Michal Marczak and Remigiusz Kozlowskiadd Show full author list remove Hide full author list
Cancers 2025, 17(3), 367; https://doi.org/10.3390/cancers17030367 - 23 Jan 2025
Cited by 1 | Viewed by 1576
Abstract
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths globally. The risk of disease increases with age, as most CRC patients are over 50 years old. Due to the progressive aging of societies in high-income countries, the problem of CRC will [...] Read more.
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths globally. The risk of disease increases with age, as most CRC patients are over 50 years old. Due to the progressive aging of societies in high-income countries, the problem of CRC will increase. This makes the development of new early detection methods and the implementation of effective screening programs crucial. Key areas of focus include raising population awareness about the importance of screening, educating high-risk populations, and improving and developing early diagnostic methods. The primary goal of this review is to provide a concise overview of recent trends and progress in CRC secondary prevention based on available information from clinical trials. Full article
(This article belongs to the Special Issue Recent Advances in Colorectal Cancer Screening)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop